Kisspeptin-13 outperforms other isoforms on beta-cell function in mouse study
KP-14 resisted plasma degradation while KP-13 and KP-10 underwent N-terminal proteolysis, with distinct metabolic effects across the three peptides.
PR
By Priya Raman · Science Reporter
Sep 16 20:00 ETSource: Metabolites
The wire
- 01In BRIN-BD11 cells, isolated murine islets and healthy mice, KP-13 was the most efficacious on insulin secretion, enhanced beta-cell proliferation more than exenatide and protected against cytokine-induced apoptosis.
- 02All three kisspeptin isoforms suppressed food intake and raised circulating glucose acutely, but KP-13 alone did not impair glucose tolerance, which the authors frame as a possible type 2 diabetes application.
- 03Work was confined to cell lines and healthy mice; no diabetic models or human data, and isoform stability differences may not translate to human plasma.
From the source
Read at pubmed.ncbi.nlm.nih.govEnzymatic Stability and Comparative Effects of Kisspeptin-14, Kisspeptin-13 and Kisspeptin-10 on Beta-Cell Function, Glucose Homeostasis and Appetite Regulation
Metabolites · 2026 Sep 17 · Spratt JA, Tanday N, McGinn DM et al.
Source URL https://pubmed.ncbi.nlm.nih.gov/42783811/
